PTGS2 and depressive symptom measurement: Our results indicate that the development of uncomplicated PUD in new users of low-dose ASA for the prevention of cardiovascular events was associated with social deprivation, a history of PUD, smoking, stress, depression, anaemia and use of NSAIDs, COX-2 inhibitors and oral steroids.